Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Oncology

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDG060PMID 12562651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

  2004cited by this paper
• Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.

  2002cited by this paper
• Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC)

  2002cited by this paper
• A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.

  2002cited by this paper
• Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.

  2001cited by this paper
• Gemcitabine/carboplatin combination regimens: importance of dose schedule.

  2000cited by this paper
• Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

  2000cited by this paper
• The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer.

  2000cited by this paper
• Scheduling of gemcitabine and cisplatin in Lewis lung tumour bearing mice.

  1999cited by this paper
• Gemcitabine-cisplatin: a schedule finding study.

  1999cited by this paper
• Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

  1999cited by this paper
• Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.

  1999cited by this paper
• Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.

  1998cited by this paper
• A phase I study of gemcitabine and carboplatin in non-small cell lung cancer.

  1996cited by this paper
• Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials

  1996cited by this paper
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.

  1995cited by this paper
• Preclinical characteristics of gemcitabine

  1995cited by this paper
• A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

  1990cited by this paper
• Stereoselective, strong inhibition of ribonucleotide reductase from E. coli by cisplatin.

  1989influential reference
• Optimal two-stage designs for phase II clinical trials.

  1989cited by this paper
• Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.

  1985cited by this paper
• Confidence limits for probability of response in multistage phase II clinical trials.

  1985cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• WHO Handbook for Reporting Results of Cancer Treatment

  1982cited by this paper
• Methods for statistical data analysis of multivariate observations

  1977cited by this paper

• A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes

  2020cites this paper
• Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.

  2011cites this paper
• Analysis of the cytotoxic activity of carboplatin and gemcitabine combination.

  2010cites this paper
• Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.

  2010cites this paper
• A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer

  2010cites this paper
• Gemcitabine in Combination with Carboplatin Exhibits Biologic Activity Against Canine Osteosarcoma

  2009cites this paper
• Gemcitabine and Carboplatin Treatment in Advanced NSCLC: A Retrospective Evaluation Including Elderly Patients

  2009cites this paper
• Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non‐small‐cell lung cancer: Is thrombocytopenia predictable?

  2009cites this paper
• FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer.

  2008cites this paper
• Differential expression of Toll-like receptors in murine peritoneal macrophages in vitro on treatment with cisplatin.

  2007cites this paper
• Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

  2007cites this paper
• Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

  2007cites this paper
• Mitomycin C and Etoposide in Advanced Colorectal Carcinoma

  2007cites this paper
• Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.

  2006cites this paper
• Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer

  2006cites this paper
• Gemcitabine: In Combination with Carboplatin in the Treatment of Recurrent Ovarian Cancer

  2005cites this paper
• Lung cancer.

  2005cites this paper
• Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?

  2004cites this paper
• Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.

  2004cites this paper